Article
Prostate cancer resistance leads to a global deregulation of translation factors and unconventional translation
28 Sept 2022
Abstract excerpt
Abstract Emerging evidence associates translation factors and regulators to tumorigenesis. However, our understanding of translational changes in cancer resistance is still limited. Here, we generated an enzalutamide-resistant prostate cancer (PCa) model, which recapitulated key features of clinical enzalutamide-resistant PCa. Using this model and poly(ribo)some profiling, we investigated global translation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
